Advertisement
Advertisement
UNCY
Unicycive Therapeutics, Inc. Common Stock
8.49
USDSponsored
+0.60
+7.60%
Jun 25, 11:33 UTC -4
Open
UNCY Earnings Reports
Positive Surprise Ratio
UNCY beat 7 of 20 last estimates.
35%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.36
Implied change from Q1 26 (Revenue/ EPS)
--
/-33.33%
Implied change from Q2 25 (Revenue/ EPS)
--
/-30.77%
Unicycive Therapeutics, Inc. Common Stock earnings per share and revenue
On May 12, 2026, UNCY reported earnings of -0.54 USD per share (EPS) for Q1 26, missing the estimate of -0.48 USD, resulting in a -11.29% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.77% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.36 USD, with revenue projected to reach -- USD, implying an decrease of -33.33% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Unicycive Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Unicycive Therapeutics, Inc. Common Stock reported EPS of -$0.54, missing estimates by -11.29%, and revenue of $0.00, 0% as expectations.
How did the market react to Unicycive Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 2.77%, changed from $7.95 before the earnings release to $8.17 the day after.
When is Unicycive Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Unicycive Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Unicycive Therapeutics, Inc. Common Stock is expected to report EPS of -$0.36 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement